Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 83

1.

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.

Moreau P, Attal M, Hulin C, Arnulf B, Belhadj K, Benboubker L, Béné MC, Broijl A, Caillon H, Caillot D, Corre J, Delforge M, Dejoie T, Doyen C, Facon T, Sonntag C, Fontan J, Garderet L, Jie KS, Karlin L, Kuhnowski F, Lambert J, Leleu X, Lenain P, Macro M, Mathiot C, Orsini-Piocelle F, Perrot A, Stoppa AM, van de Donk NW, Wuilleme S, Zweegman S, Kolb B, Touzeau C, Roussel M, Tiab M, Marolleau JP, Meuleman N, Vekemans MC, Westerman M, Klein SK, Levin MD, Fermand JP, Escoffre-Barbe M, Eveillard JR, Garidi R, Ahmadi T, Zhuang S, Chiu C, Pei L, de Boer C, Smith E, Deraedt W, Kampfenkel T, Schecter J, Vermeulen J, Avet-Loiseau H, Sonneveld P.

Lancet. 2019 Jul 6;394(10192):29-38. doi: 10.1016/S0140-6736(19)31240-1. Epub 2019 Jun 3. Erratum in: Lancet. 2019 Jun 14;:.

PMID:
31171419
2.

Development and Validation of a Cytogenetic Prognostic Index Predicting Survival in Multiple Myeloma.

Perrot A, Lauwers-Cances V, Tournay E, Hulin C, Chretien ML, Royer B, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Fontan J, Voillat L, Demarquette H, Collet P, Rodon P, Sohn C, Lifermann F, Orsini-Piocelle F, Richez V, Mohty M, Macro M, Minvielle S, Moreau P, Leleu X, Facon T, Attal M, Avet-Loiseau H, Corre J.

J Clin Oncol. 2019 Jul 1;37(19):1657-1665. doi: 10.1200/JCO.18.00776. Epub 2019 May 15.

PMID:
31091136
3.

Multiple myeloma immunophenotyping: method validation.

Vergnolle I, Rieu JB, Avet-Loiseau H, Corre J, Vergez F.

Ann Biol Clin (Paris). 2019 Apr 1;77(2):197-217. doi: 10.1684/abc.2019.1426.

PMID:
30998199
4.

Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma.

Pertesi M, Vallée M, Wei X, Revuelta MV, Galia P, Demangel D, Oliver J, Foll M, Chen S, Perrial E, Garderet L, Corre J, Leleu X, Boyle EM, Decaux O, Rodon P, Kolb B, Slama B, Mineur P, Voog E, Le Bris C, Fontan J, Maigre M, Beaumont M, Azais I, Sobol H, Vignon M, Royer B, Perrot A, Fuzibet JG, Dorvaux V, Anglaret B, Cony-Makhoul P, Berthou C, Desquesnes F, Pegourie B, Leyvraz S, Mosser L, Frenkiel N, Augeul-Meunier K, Leduc I, Leyronnas C, Voillat L, Casassus P, Mathiot C, Cheron N, Paubelle E, Moreau P, Bignon YJ, Joly B, Bourquard P, Caillot D, Naman H, Rigaudeau S, Marit G, Macro M, Lambrecht I, Cliquennois M, Vincent L, Helias P, Avet-Loiseau H, Moreno V, Reis RM, Varkonyi J, Kruszewski M, Vangsted AJ, Jurczyszyn A, Zaucha JM, Sainz J, Krawczyk-Kulis M, Wątek M, Pelosini M, Iskierka-Jażdżewska E, Grząśko N, Martinez-Lopez J, Jerez A, Campa D, Buda G, Lesueur F, Dudziński M, García-Sanz R, Nagler A, Rymko M, Jamroziak K, Butrym A, Canzian F, Obazee O, Nilsson B, Klein RJ, Lipkin SM, McKay JD, Dumontet C.

Leukemia. 2019 Apr 9. doi: 10.1038/s41375-019-0452-6. [Epub ahead of print] No abstract available.

PMID:
30967618
5.

Inhibitors of the Neisseria meningitidis PilF ATPase provoke type IV pilus disassembly.

Aubey F, Corre JP, Kong Y, Xu X, Obino D, Goussard S, Lapeyrere C, Souphron J, Couturier C, Renard S, Duménil G.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8481-8486. doi: 10.1073/pnas.1817757116. Epub 2019 Apr 4.

PMID:
30948644
6.

Inter-observer and segmentation method variability of textural analysis in pre-therapeutic FDG PET/CT in head and neck cancer.

Guezennec C, Bourhis D, Orlhac F, Robin P, Corre JB, Delcroix O, Gobel Y, Schick U, Salaün PY, Abgral R.

PLoS One. 2019 Mar 28;14(3):e0214299. doi: 10.1371/journal.pone.0214299. eCollection 2019.

7.

[Rationalization of biological tests in cardiology department].

Corré J, Douard H.

Sante Publique. 2018 September October;30(5):689-695. doi: 10.3917/spub.186.0689. French.

PMID:
30767484
8.

Risk-Based Therapeutic Strategies.

Corre J, Avet-Loiseau H.

Cancer J. 2019 Jan/Feb;25(1):54-58. doi: 10.1097/PPO.0000000000000352.

PMID:
30694860
9.

High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma.

Thakurta A, Ortiz M, Blecua P, Towfic F, Corre J, Serbina NV, Flynt E, Yu Z, Yang Z, Palumbo A, Dimopoulos MA, Gutierrez NC, Goldschmidt H, Sonneveld P, Avet-Loiseau H.

Blood. 2019 Mar 14;133(11):1217-1221. doi: 10.1182/blood-2018-10-880831. Epub 2019 Jan 28.

10.

Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements.

Dejoie T, Corre J, Caillon H, Moreau P, Attal M, Loiseau HA.

Leukemia. 2019 Feb;33(2):313-318. doi: 10.1038/s41375-018-0339-y. Epub 2018 Dec 20. Review.

11.

Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14).

Cleynen A, Samur M, Perrot A, Buisson L, Maheo S, Fulciniti M, Attal M, Munshi N, Avet-Loiseau H, Corre J.

Blood. 2018 Dec 27;132(26):2778-2780. doi: 10.1182/blood-2018-09-876433. Epub 2018 Nov 14. No abstract available.

PMID:
30429160
12.

Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement.

Corre J, van Zessen R, Loureiro M, Patriarchi T, Tian L, Pascoli V, Lüscher C.

Elife. 2018 Oct 30;7. pii: e39945. doi: 10.7554/eLife.39945.

13.

Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow.

Mazzotti C, Buisson L, Maheo S, Perrot A, Chretien ML, Leleu X, Hulin C, Manier S, Hébraud B, Roussel M, Do Souto L, Attal M, Avet-Loiseau H, Corre J.

Blood Adv. 2018 Nov 13;2(21):2811-2813. doi: 10.1182/bloodadvances.2018025197. No abstract available.

14.

Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.

Perrot A, Lauwers-Cances V, Corre J, Robillard N, Hulin C, Chretien ML, Dejoie T, Maheo S, Stoppa AM, Pegourie B, Karlin L, Garderet L, Arnulf B, Doyen C, Meuleman N, Royer B, Eveillard JR, Benboubker L, Dib M, Decaux O, Jaccard A, Belhadj K, Brechignac S, Kolb B, Fohrer C, Mohty M, Macro M, Richardson PG, Carlton V, Moorhead M, Willis T, Faham M, Anderson KC, Harousseau JL, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H, Munshi N.

Blood. 2018 Dec 6;132(23):2456-2464. doi: 10.1182/blood-2018-06-858613. Epub 2018 Sep 24.

PMID:
30249784
15.

IgG lymphoplasmacytic lymphoma: a case report.

Vergnolle I, Sigur N, Corre J.

Ann Biol Clin (Paris). 2018 Dec 1;76(6):665-668. doi: 10.1684/abc.2018.1384.

PMID:
30238920
16.

Risk Stratification and Targets in Multiple Myeloma: From Genomics to the Bedside.

Perrot A, Corre J, Avet-Loiseau H.

Am Soc Clin Oncol Educ Book. 2018 May 23;38:675-680. doi: 10.1200/EDBK_200879. Review.

PMID:
30231368
17.

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when.

Caers J, Garderet L, Kortüm KM, O'Dwyer ME, van de Donk NWCJ, Binder M, Dold SM, Gay F, Corre J, Beguin Y, Ludwig H, Larocca A, Driessen C, Dimopoulos MA, Boccadoro M, Gramatzki M, Zweegman S, Einsele H, Cavo M, Goldschmidt H, Sonneveld P, Delforge M, Auner HW, Terpos E, Engelhardt M.

Haematologica. 2018 Nov;103(11):1772-1784. doi: 10.3324/haematol.2018.189159. Epub 2018 Aug 31.

18.

Multiple myeloma clonal evolution in homogeneously treated patients.

Corre J, Cleynen A, Robiou du Pont S, Buisson L, Bolli N, Attal M, Munshi N, Avet-Loiseau H.

Leukemia. 2018 Dec;32(12):2636-2647. doi: 10.1038/s41375-018-0153-6. Epub 2018 Jun 12.

19.

Electrical storm in the early phase of HeartMate® II device implantation: Incidence, risk factors and prognosis.

Corre J, Picard F, Garcia R, Zemmoura A, Derval N, Denis A, Romen A, Nubret K, Jais P, Haissaguerre M, Dos Santos P, Barandon L, Sacher F.

Arch Cardiovasc Dis. 2018 May;111(5):332-339. doi: 10.1016/j.acvd.2017.07.006. Epub 2017 Dec 6.

20.

Expressed fusion gene landscape and its impact in multiple myeloma.

Cleynen A, Szalat R, Kemal Samur M, Robiou du Pont S, Buisson L, Boyle E, Chretien ML, Anderson K, Minvielle S, Moreau P, Attal M, Parmigiani G, Corre J, Munshi N, Avet-Loiseau H.

Nat Commun. 2017 Dec 1;8(1):1893. doi: 10.1038/s41467-017-00638-w.

21.

Effect of replacing main-chain ureas with thiourea and guanidinium surrogates on the bactericidal activity of membrane active oligourea foldamers.

Antunes S, Corre JP, Mikaty G, Douat C, Goossens PL, Guichard G.

Bioorg Med Chem. 2017 Aug 15;25(16):4245-4252. doi: 10.1016/j.bmc.2017.04.040. Epub 2017 Apr 29.

PMID:
28687228
22.

An unusual cause of myocardial ischemia: Compression of a left internal mammary artery grafting to the left anterior descending artery by a pacemaker lead.

Corré J, Chassaing S, Arnould MA, Barbey C, Bar O, Blanchard D.

J Cardiol Cases. 2017 Jun 22;16(3):74-76. doi: 10.1016/j.jccase.2017.05.006. eCollection 2017 Sep.

23.

A strange nature of right ventricular tumour: the first case report of osseous metaplasia in the heart.

Corré J, Chassaing S, Lepage O, Blanchard D.

Eur Heart J Cardiovasc Imaging. 2017 Sep 1;18(9):1069. doi: 10.1093/ehjci/jex098. No abstract available.

PMID:
28444159
24.

Genomics of Multiple Myeloma.

Robiou du Pont S, Cleynen A, Fontan C, Attal M, Munshi N, Corre J, Avet-Loiseau H.

J Clin Oncol. 2017 Mar 20;35(9):963-967. doi: 10.1200/JCO.2016.70.6705. Epub 2017 Feb 13. Review.

PMID:
28297630
25.

An unusual cause of cardiogenic shock: Left atrial compression by a spontaneous rupture of an aneurysm of the descending thoracic aorta.

Corré J, Chassaing S, Blanchard D.

J Cardiol Cases. 2017 Mar 6;15(5):153-154. doi: 10.1016/j.jccase.2016.12.009. eCollection 2017 May.

26.

Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma.

Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, Chretien ML, Fontan J, Belhadj K, Brechignac S, Decaux O, Voillat L, Rodon P, Fitoussi O, Araujo C, Benboubker L, Fontan C, Tiab M, Godmer P, Luycx O, Allangba O, Pignon JM, Fuzibet JG, Legros L, Stoppa AM, Dib M, Pegourie B, Orsini-Piocelle F, Karlin L, Arnulf B, Roussel M, Garderet L, Mohty M, Meuleman N, Doyen C, Lenain P, Macro M, Leleu X, Facon T, Moreau P, Attal M, Avet-Loiseau H.

Blood. 2016 Dec 22;128(25):2941-2948. doi: 10.1182/blood-2016-07-726778. Epub 2016 Oct 11.

27.

Proteolytically Stable Foldamer Mimics of Host-Defense Peptides with Protective Activities in a Murine Model of Bacterial Infection.

Teyssières E, Corre JP, Antunes S, Rougeot C, Dugave C, Jouvion G, Claudon P, Mikaty G, Douat C, Goossens PL, Guichard G.

J Med Chem. 2016 Sep 22;59(18):8221-32. doi: 10.1021/acs.jmedchem.6b00144. Epub 2016 Sep 9.

PMID:
27529632
28.

Physical Sequestration of Bacillus anthracis in the Pulmonary Capillaries in Terminal Infection.

Jouvion G, Corre JP, Khun H, Moya-Nilges M, Roux P, Latroche C, Tournier JN, Huerre M, Chrétien F, Goossens PL.

J Infect Dis. 2016 Jul 15;214(2):281-7. doi: 10.1093/infdis/jiw098. Epub 2016 Mar 14.

PMID:
26977051
29.

Low doses of a neonicotinoid insecticide modify pheromone response thresholds of central but not peripheral olfactory neurons in a pest insect.

Rabhi KK, Deisig N, Demondion E, Le Corre J, Robert G, Tricoire-Leignel H, Lucas P, Gadenne C, Anton S.

Proc Biol Sci. 2016 Feb 10;283(1824). pii: 20152987. doi: 10.1098/rspb.2015.2987.

30.

Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?

Chretien ML, Corre J, Lauwers-Cances V, Magrangeas F, Cleynen A, Yon E, Hulin C, Leleu X, Orsini-Piocelle F, Blade JS, Sohn C, Karlin L, Delbrel X, Hebraud B, Roussel M, Marit G, Garderet L, Mohty M, Rodon P, Voillat L, Royer B, Jaccard A, Belhadj K, Fontan J, Caillot D, Stoppa AM, Attal M, Facon T, Moreau P, Minvielle S, Avet-Loiseau H.

Blood. 2015 Dec 17;126(25):2713-9. doi: 10.1182/blood-2015-06-650242. Epub 2015 Oct 29.

31.

[Lifestyle changes for patients with coronary artery disease].

Douard H, Corré J.

Rev Prat. 2015 Mar;65(3):357-8, 360-2. French.

PMID:
26016195
32.

Characteristics of ventricular tachycardia ablation in patients with continuous flow left ventricular assist devices.

Sacher F, Reichlin T, Zado ES, Field ME, Viles-Gonzalez JF, Peichl P, Ellenbogen KA, Maury P, Dukkipati SR, Picard F, Kautzner J, Barandon L, Koneru JN, Ritter P, Mahida S, Calderon J, Derval N, Denis A, Cochet H, Shepard RK, Corre J, Coffey JO, Garcia F, Hocini M, Tedrow U, Haissaguerre M, d'Avila A, Stevenson WG, Marchlinski FE, Jais P.

Circ Arrhythm Electrophysiol. 2015 Jun;8(3):592-7. doi: 10.1161/CIRCEP.114.002394. Epub 2015 Apr 13.

PMID:
25870335
33.

Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.

Devillier R, Mansat-De Mas V, Gelsi-Boyer V, Demur C, Murati A, Corre J, Prebet T, Bertoli S, Brecqueville M, Arnoulet C, Recher C, Vey N, Mozziconacci MJ, Delabesse E, Birnbaum D.

Oncotarget. 2015 Apr 10;6(10):8388-96.

34.

Capsules, toxins and AtxA as virulence factors of emerging Bacillus cereus biovar anthracis.

Brézillon C, Haustant M, Dupke S, Corre JP, Lander A, Franz T, Monot M, Couture-Tosi E, Jouvion G, Leendertz FH, Grunow R, Mock ME, Klee SR, Goossens PL.

PLoS Negl Trop Dis. 2015 Apr 1;9(4):e0003455. doi: 10.1371/journal.pntd.0003455. eCollection 2015 Apr. Erratum in: PLoS Negl Trop Dis. 2015 Apr;9(4):e0003746.

35.

The use of Impella 2.5 in severe refractory cardiogenic shock complicating an acute myocardial infarction.

Casassus F, Corre J, Leroux L, Chevalereau P, Fresselinat A, Seguy B, Calderon J, Coste P, Ouattara A, Roques X, Barandon L.

J Interv Cardiol. 2015 Feb;28(1):41-50. doi: 10.1111/joic.12172.

PMID:
25689547
36.

Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience.

Hebraud B, Magrangeas F, Cleynen A, Lauwers-Cances V, Chretien ML, Hulin C, Leleu X, Yon E, Marit G, Karlin L, Roussel M, Stoppa AM, Belhadj K, Voillat L, Garderet L, Macro M, Caillot D, Mohty M, Facon T, Moreau P, Attal M, Munshi N, Corre J, Minvielle S, Avet-Loiseau H.

Blood. 2015 Mar 26;125(13):2095-100. doi: 10.1182/blood-2014-07-587964. Epub 2015 Jan 30.

37.

Genetics of multiple myeloma: another heterogeneity level?

Corre J, Munshi N, Avet-Loiseau H.

Blood. 2015 Mar 19;125(12):1870-6. doi: 10.1182/blood-2014-10-567370. Epub 2015 Jan 27. Review.

38.

Unexpected effects of low doses of a neonicotinoid insecticide on behavioral responses to sex pheromone in a pest insect.

Rabhi KK, Esancy K, Voisin A, Crespin L, Le Corre J, Tricoire-Leignel H, Anton S, Gadenne C.

PLoS One. 2014 Dec 17;9(12):e114411. doi: 10.1371/journal.pone.0114411. eCollection 2014.

39.

Front-line transplantation program with lenalidomide, bortezomib, and dexamethasone combination as induction and consolidation followed by lenalidomide maintenance in patients with multiple myeloma: a phase II study by the Intergroupe Francophone du Myélome.

Roussel M, Lauwers-Cances V, Robillard N, Hulin C, Leleu X, Benboubker L, Marit G, Moreau P, Pegourie B, Caillot D, Fruchart C, Stoppa AM, Gentil C, Wuilleme S, Huynh A, Hebraud B, Corre J, Chretien ML, Facon T, Avet-Loiseau H, Attal M.

J Clin Oncol. 2014 Sep 1;32(25):2712-7. doi: 10.1200/JCO.2013.54.8164. Epub 2014 Jul 14.

PMID:
25024076
40.

Blastic island in acute myeloid leukemia.

Corre J, Récher C.

Blood. 2014 Mar 27;123(13):1986. No abstract available.

41.

Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients.

Chretien ML, Hebraud B, Cances-Lauwers V, Hulin C, Marit G, Leleu X, Karlin L, Roussel M, Stoppa AM, Guilhot F, Lamy T, Garderet L, Pegourie B, Dib M, Sebban C, Lenain P, Brechignac S, Royer B, Wetterwald M, Legros L, Orsini-Piocelle F, Voillat L, Delbrel X, Caillot D, Macro M, Facon T, Attal M, Moreau P, Avet-Loiseau H, Corre J.

Haematologica. 2014 Jul;99(7):1236-8. doi: 10.3324/haematol.2013.098608. Epub 2014 Apr 11.

42.

Growth differentiation factor 15 in multiple myeloma: a microenvironment factor predictive of response to treatment?

Corre J.

Acta Haematol. 2014;131(3):170-2. doi: 10.1159/000355129. Epub 2013 Nov 9. No abstract available.

PMID:
24216505
43.

Concise review: growth differentiation factor 15 in pathology: a clinical role?

Corre J, Hébraud B, Bourin P.

Stem Cells Transl Med. 2013 Dec;2(12):946-52. doi: 10.5966/sctm.2013-0055. Epub 2013 Nov 4. Review.

44.

Hemophagocytic syndrome in patients with acute myeloid leukemia undergoing intensive chemotherapy.

Delavigne K, Bérard E, Bertoli S, Corre J, Duchayne E, Demur C, Mansat-De Mas V, Borel C, Picard M, Alvarez M, Sarry A, Huguet F, Récher C.

Haematologica. 2014 Mar;99(3):474-80. doi: 10.3324/haematol.2013.097394. Epub 2013 Oct 18.

45.

Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients.

Hebraud B, Leleu X, Lauwers-Cances V, Roussel M, Caillot D, Marit G, Karlin L, Hulin C, Gentil C, Guilhot F, Garderet L, Lamy T, Brechignac S, Pegourie B, Jaubert J, Dib M, Stoppa AM, Sebban C, Fohrer C, Fontan J, Fruchart C, Macro M, Orsini-Piocelle F, Lepeu G, Sohn C, Corre J, Facon T, Moreau P, Attal M, Avet-Loiseau H.

Leukemia. 2014 Mar;28(3):675-9. doi: 10.1038/leu.2013.225. Epub 2013 Jul 29.

46.

The translocation t(4;14) can be present only in minor subclones in multiple myeloma.

Hébraud B, Caillot D, Corre J, Marit G, Hulin C, Leleu X, Lodé L, Wetterwald M, Dib M, Rodon P, Voillat L, Royer B, Voog E, Fitoussi O, Stoppa AM, Garderet L, Kolb B, Maigre M, Boullanger N, Allangba O, Karlin L, Daguindau N, Legros L, Sohn C, Joubert MV, Lenain P, Facon T, Attal M, Moreau P, Avet-Loiseau H.

Clin Cancer Res. 2013 Sep 1;19(17):4634-7. doi: 10.1158/1078-0432.CCR-12-3866. Epub 2013 Jul 15.

47.

Methadone-induced toxic brain damage.

Corré J, Pillot J, Hilbert G.

Case Rep Radiol. 2013;2013:602981. doi: 10.1155/2013/602981. Epub 2013 May 22.

48.

Caseous necrosis of mitral annulus: a rare cause of stroke.

Corre J, Leroux L, Coste P.

Case Rep Cardiol. 2013;2013:748241. doi: 10.1155/2013/748241. Epub 2013 May 12.

49.

High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia.

Pasquet M, Bellanné-Chantelot C, Tavitian S, Prade N, Beaupain B, Larochelle O, Petit A, Rohrlich P, Ferrand C, Van Den Neste E, Poirel HA, Lamy T, Ouachée-Chardin M, Mansat-De Mas V, Corre J, Récher C, Plat G, Bachelerie F, Donadieu J, Delabesse E.

Blood. 2013 Jan 31;121(5):822-9. doi: 10.1182/blood-2012-08-447367. Epub 2012 Dec 6.

50.

In vivo germination of Bacillus anthracis spores during murine cutaneous infection.

Corre JP, Piris-Gimenez A, Moya-Nilges M, Jouvion G, Fouet A, Glomski IJ, Mock M, Sirard JC, Goossens PL.

J Infect Dis. 2013 Feb 1;207(3):450-7. doi: 10.1093/infdis/jis686. Epub 2012 Nov 12.

PMID:
23148288

Supplemental Content

Support Center